Advanced search
Publication Cover
Climacteric Volume 6, 2003 - Issue 2
Submit an article Journal homepage
65
Views
13
CrossRef citations to date
0
Altmetric
(RG) Obstetrics and Gynaecology

Factors affecting long-term adherence to hormone replacement therapy after screening for osteoporosis

S. A. Steel Centre for Metabolic Bone Disease, University of Hull, UK
,
P. Albertazzi Centre for Metabolic Bone Disease, University of Hull, UK
,
E. M. Howarth Centre for Metabolic Bone Disease, University of Hull, UK
&
D. W. Purdie Centre for Metabolic Bone Disease, University of Hull, UK
Pages 96-103 | Published online: 03 Jul 2009

References

  • Writing Group for the Women's Health Initia-tive. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;288:321–33
  • Law MR, Wald NJ, Meade TW. Strategies for prevention of osteoporosis and hip fracture. Br Med J 1991;3:453–9
  • Garton M, Reid D, Rennie E. The climacteric, osteoporosis and hormone replacement; views of women 45–49. Maturitas 1995;21: 7–15
  • Ettinger B, Pressman A. Continuation of post-menopausal hormone replacement therapy in a large health maintenance organization: trans-dermal matrix patch versus oral estrogen therapy. Am J Managed Care 1999;5:779–85
  • Hope S. Why do women start and stop HRT? J Br Menopause Soc 1995;1:26–9
  • Purdie DW, Steel SA, Howey S, Doherty SM. The technical feasibility of population densitometry using DXA and directed HRT intervention: a 2-year prospective study. Osteoporos Int 1996; 3:S31–6
  • Eiken P, Kolthoff N. Adherence with long term hormonal replacement therapy. Maturitas 1995; 22:97–103
  • Ettinger B, Li DK, Klein R. Continuation of postmenopausal hormone replacement therapy; comparison of cyclic versus continuous com-bined schedules. Menopause 1996;3:185–9
  • Ryan PJ, Harrison R, Blacke GM, Fogelman I. Adherence with hormone replacement therapy (HRT) after screening for postmenopausal osteo-porosis. Br J Obstet Gynaecol 1992;99:325–8
  • World Health Organization. Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis. WHO technical report series 843. Geneva: WHO, 1994
  • Jacobs HS, Loeffler FE. Postmenopausal hormone replacement therapy. Br Med J 1992; 305:1403–8
  • Ravnikar VA. Adherence with hormone replace-ment therapy. Am J Obstet Gynecol 1987;156: 1332–4
  • Sullivan JM. Estrogen replacement therapy. Am J Med 1996;10(Suppl 4A):4A565–605
  • Pillon D, Castilloux AM, Lelorier J. Estrogen replacement therapy: determinants of persistence with treatment. Obstet Gynecol 2001;97:97–100
  • Rimes KA, Salkovskis PM, Shipmen JA. Psycho-logical and behavioral effects of bone density screening for osteoporosis. Psych ol Health 1999; 14:585–608
  • Rubin S, Cummings SR. Results of bone densito-metry affects women's decision about taking measures to prevent fractures. Ann Intern Med 1992;116:990–5
  • Writing Group for the Postmenopausal Estrogen/Progestin Interventions trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. J Am Med Assoc 1995;273:199–208
  • Hill DA, Weiss NS, La Croix AZ. Adherence to postmenopausal hormone replacement therapy during the year after initial prescription: a population-based study. Am J Obstet Gynecol 2000;182:270–6
  • Lawrence M, Jones L, Lancaster T, Daly E, Barks E. Hormone replacement therapy: patterns of use studied through British general practice com-puterized records. Fam Pract 1999;16:335–42
  • Tosteson ANA, Rosenthal DI, Melton JL, Weinstein MC. Cost effectiveness of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement therapy. Ann Intern Med 1990;113:593–603
  • Anderson E, Hamburger S, Liu J, Rebar RW. Characteristics of menopausal women seeking assistance. Am J Obstet Gynecol 1987;156: 428–33
  • Li C, Samsioe G, Lidfelt J, Nerbrand C, Agardh CD. Important factors for use of hormone replacement therapy: a population-based study Lund Area (WHILA) Study. Menopause 2000; 7:273–81
  • Khastgir G, Studd J. Patients' outlook, experi- Cano A. Adherence to hormone replacement therapy in menopausal women controlled in a third level academic centre. Maturitas 1994; 20:91–9 Stevenson JC, Bees B, Devenport M, Gust MP, Ganger KF. Determinants of bone density in normal women: risk factor for osteoporosis. Br Med J 1989;298:924-8
  • Cano A. Adherence to hormone replacement therapy in menopausal women controlled in a third level academic centre. Maturitas 1994; 20:91�9
  • Stevenson JC, Bees B, Devenport M, Cust MP, Ganger KF. Determinants of bone density in normal women: risk factor for osteoporosis. Br Med J 1989;298:924�8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.